Stocks and securities in focus
| Security ▲ | Change (%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| AbbVie Inc. | -2.480% | -2.844% | -9.674% | 11.064% | 8.765% | 64.238% | 115.287% |
| AnaptysBio Inc | 14.570% | 27.374% | 9.615% | 21.277% | 17.526% | 18.750% | - |
| Ardelyx Inc. | 3.540% | -0.366% | -11.361% | 47.951% | 3.668% | -1.770% | - |
| Atara Biotherapeutics Inc. | -13.970% | 2.482% | 12.231% | -72.415% | 32.576% | -94.200% | - |
| Brainstorm Cell | 7.270% | -29.447% | -33.143% | -87.283% | 51.293% | -87.897% | - |
| Bristol-Myers Squibb | -0.020% | -9.864% | -17.834% | -32.071% | -11.282% | -20.715% | -0.387% |
| Cardiff Oncology Inc. | -3.130% | 4.487% | -17.343% | 159.554% | 209.650% | -48.418% | 16.429% |
| Coherus Bioscien. | 5.050% | 2.272% | -12.222% | -70.540% | -36.332% | -84.760% | -86.480% |
| Cytomx Therapeutics Inc | 175.590% | 0.262% | -23.323% | 3.235% | 9.742% | -80.308% | - |
| Fate Therapeutics Inc. | 0.510% | -8.103% | -45.632% | -30.166% | 3.965% | -94.909% | - |
| Heron Therapeutics Inc. | 2.120% | -16.922% | -15.234% | 0.463% | 38.217% | -85.060% | - |
| ImmunityBio Inc. | 9.150% | 66.089% | 49.480% | 194.252% | 58.347% | -49.404% | - |
| Neogenomicsinc. | -1.530% | 3.150% | -7.092% | -1.504% | -16.026% | -67.829% | - |
| PTC Therapeutics Inc. | 12.030% | 27.350% | 12.030% | -36.325% | 18.254% | -12.353% | -9.670% |
| Radius Health Inc. | - | - | - | - | - | - | - |
| Salarius Pharmaceuticals Inc. | -2.830% | -3.738% | -2.830% | -71.389% | -25.766% | -98.474% | -99.994% |
| Viking Therapeutics Inc | -5.580% | 22.639% | -1.714% | 285.618% | 326.308% | 1301.128% | - |
| Voyager Therapeutics Inc | 9.230% | 2.182% | -17.500% | 10.000% | -8.679% | 80.507% | - |